121 related articles for article (PubMed ID: 35467108)
1. Correction to: Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Žilionytė K; Bagdzevičiūtė U; Mlynska A; Urbštaitė E; Paberalė E; Dobrovolskienė N; Krasko JA; Pašukonienė V
Cancer Immunol Immunother; 2022 Nov; 71(11):2701. PubMed ID: 35467108
[No Abstract] [Full Text] [Related]
2. Functional antigen processing and presentation mechanism as a prerequisite factor of response to treatment with dendritic cell vaccines and anti-PD-1 in preclinical murine LLC1 and GL261 tumor models.
Žilionytė K; Bagdzevičiūtė U; Mlynska A; Urbštaitė E; Paberalė E; Dobrovolskienė N; Krasko JA; Pašukonienė V
Cancer Immunol Immunother; 2022 Nov; 71(11):2691-2700. PubMed ID: 35364740
[TBL] [Abstract][Full Text] [Related]
3. Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1.
Sun C; Nagaoka K; Kobayashi Y; Nakagawa H; Kakimi K; Nakajima J
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771674
[TBL] [Abstract][Full Text] [Related]
4. Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.
Renner DN; Jin F; Litterman AJ; Balgeman AJ; Hanson LM; Gamez JD; Chae M; Carlson BL; Sarkaria JN; Parney IF; Ohlfest JR; Pirko I; Pavelko KD; Johnson AJ
PLoS One; 2015; 10(5):e0125565. PubMed ID: 25933216
[TBL] [Abstract][Full Text] [Related]
5. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
[TBL] [Abstract][Full Text] [Related]
6. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
[TBL] [Abstract][Full Text] [Related]
7. Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas.
Ni HT; Spellman SR; Jean WC; Hall WA; Low WC
J Neurooncol; 2001 Jan; 51(1):1-9. PubMed ID: 11349874
[TBL] [Abstract][Full Text] [Related]
8. Platinum-based chemotherapy in combination with PD-1/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action.
Xue Y; Gao S; Gou J; Yin T; He H; Wang Y; Zhang Y; Tang X; Wu R
Expert Opin Drug Deliv; 2021 Feb; 18(2):187-203. PubMed ID: 32954856
[TBL] [Abstract][Full Text] [Related]
9. Anti-PD-1 checkpoint blockade monotherapy in the orthotopic GL261 glioma model: the devil is in the detail.
Tritz ZP; Ayasoufi K; Johnson AJ
Neurooncol Adv; 2021; 3(1):vdab066. PubMed ID: 34151268
[TBL] [Abstract][Full Text] [Related]
10. GL261 luciferase-expressing cells elicit an anti-tumor immune response: an evaluation of murine glioma models.
Sanchez VE; Lynes JP; Walbridge S; Wang X; Edwards NA; Nwankwo AK; Sur HP; Dominah GA; Obungu A; Adamstein N; Dagur PK; Maric D; Munasinghe J; Heiss JD; Nduom EK
Sci Rep; 2020 Jul; 10(1):11003. PubMed ID: 32620877
[TBL] [Abstract][Full Text] [Related]
11. Superior efficacy of tumor cell vaccines grown in physiologic oxygen.
Olin MR; Andersen BM; Zellmer DM; Grogan PT; Popescu FE; Xiong Z; Forster CL; Seiler C; SantaCruz KS; Chen W; Blazar BR; Ohlfest JR
Clin Cancer Res; 2010 Oct; 16(19):4800-8. PubMed ID: 20858839
[TBL] [Abstract][Full Text] [Related]
12. Anti-PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression.
Tritz ZP; Ayasoufi K; Wolf DM; Owens CA; Malo CS; Himes BT; Fain CE; Goddery EN; Yokanovich LT; Jin F; Hansen MJ; Parney IF; Wang C; Moynihan KD; Irvine DJ; Wittrup KD; Diaz Marcano RM; Vile RG; Johnson AJ
Cancer Immunol Res; 2023 Jun; 11(6):763-776. PubMed ID: 36921098
[TBL] [Abstract][Full Text] [Related]
13. Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling.
Dastmalchi F; Karachi A; Yang C; Azari H; Sayour EJ; Dechkovskaia A; Vlasak AL; Saia ME; Lovaton RE; Mitchell DA; Rahman M
J Immunother Cancer; 2019 Nov; 7(1):321. PubMed ID: 31753028
[TBL] [Abstract][Full Text] [Related]
14. CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma.
Diggs LP; Ruf B; Ma C; Heinrich B; Cui L; Zhang Q; McVey JC; Wabitsch S; Heinrich S; Rosato U; Lai W; Subramanyam V; Longerich T; Loosen SH; Luedde T; Neumann UP; Desar S; Kleiner D; Gores G; Wang XW; Greten TF
J Hepatol; 2021 May; 74(5):1145-1154. PubMed ID: 33276030
[TBL] [Abstract][Full Text] [Related]
15. Mouse glioma immunotherapy mediated by A2B5+ GL261 cell lysate-pulsed dendritic cells.
Xu M; Yao Y; Hua W; Wu Z; Zhong P; Mao Y; Zhou L; Luo F; Chu Y
J Neurooncol; 2014 Feb; 116(3):497-504. PubMed ID: 24398615
[TBL] [Abstract][Full Text] [Related]
16. CD137 and PD-L1 targeting with immunovirotherapy induces a potent and durable antitumor immune response in glioblastoma models.
Puigdelloses M; Garcia-Moure M; Labiano S; Laspidea V; Gonzalez-Huarriz M; Zalacain M; Marrodan L; Martinez-Velez N; De la Nava D; Ausejo I; Hervás-Stubbs S; Herrador G; Chen Z; Hambardzumyan D; Patino Garcia A; Jiang H; Gomez-Manzano C; Fueyo J; Gállego Pérez-Larraya J; Alonso M
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34281988
[TBL] [Abstract][Full Text] [Related]
17. Gene and miRNA expression signature of Lewis lung carcinoma LLC1 cells in extracellular matrix enriched microenvironment.
Stankevicius V; Vasauskas G; Bulotiene D; Butkyte S; Jarmalaite S; Rotomskis R; Suziedelis K
BMC Cancer; 2016 Oct; 16(1):789. PubMed ID: 27729023
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas.
Ciesielski MJ; Apfel L; Barone TA; Castro CA; Weiss TC; Fenstermaker RA
Cancer Immunol Immunother; 2006 Dec; 55(12):1491-503. PubMed ID: 16485128
[TBL] [Abstract][Full Text] [Related]
19. Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism.
Patel JM; Cui Z; Wen ZF; Dinh CT; Hu HM
J Immunother Cancer; 2019 Nov; 7(1):311. PubMed ID: 31747946
[TBL] [Abstract][Full Text] [Related]
20. Irradiation-Modulated Murine Brain Microenvironment Enhances GL261-Tumor Growth and Inhibits Anti-PD-L1 Immunotherapy.
Garbow JR; Johanns TM; Ge X; Engelbach JA; Yuan L; Dahiya S; Tsien CI; Gao F; Rich KM; Ackerman JJH
Front Oncol; 2021; 11():693146. PubMed ID: 34249742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]